The SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in adults with established cardiovascular disease and obesity, without any requirement for type 2 diabetes [5]
At TrimBody M.D., we focus on combining proven science with professional guidance to give you effective, lasting results
Multiple sclerosis: Major histocompatibility complexity and antigen presentation
Contact us today to learn more about GLP-1 and our weight loss programs featuring semaglutide, tirzepatide, and other options
Adems, aunque los GLP-1 y similares pueden ser muy tiles, la dieta equilibrada y la actividad fsica siguen siendo el pilar de cualquier abordaje, ya que los medicamentos, por s solos, no lo resuelven todo
If present, discontinuation should be considered, following the ASA guidance: withholding on the day of surgery for daily formulations and 1 week prior for weekly ones